다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Cancer research : the official organ of the American Association for Cancer Research, Inc, v.78 no.6, 2018년, pp.1572 - 1573
Kwon, Byungsuk (School of Biological Sciences and Biomedical Research Center, University of Ulsan, Ulsan, Republic of Korea.)
초록이 없습니다.
OncoImmunol Dharmadhikari 5 e1113367 2016 10.1080/2162402X.2015.1113367 CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses
Immunity Zhu 34 466 2011 10.1016/j.immuni.2011.04.008 Cell surface signalling molecules in the control of immune responses: a tidal model
Proc Natl Acad Sci U S A Kim 109 E13 2012 Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation
J Immunol Kwon 168 5483 2002 10.4049/jimmunol.168.11.5483 Immune responses in 4-1BB (CD137)-deficient mice
J Immunol Eun 194 134 2015 10.4049/jimmunol.1401383 4-1BB ligand signaling to T cells limits T cell activation
Cancer Res Kang 77 5989 2017 10.1158/0008-5472.CAN-17-0610 Anti-CD137 suppresses tumor growth by blocking reverse signaling by CD137 ligand
PLoS One Martinez Gomez 8 e73277 2013 10.1371/journal.pone.0073277 CD137 facilitates the resolution of acute DSS-induced colonic inflammation in mice
Cancer Res Dharmadhikari 78 1571 2017 10.1158/0008-5472.CAN-17-2997 Anti-CD137 cancer immunotherapy suppresses tumor growth-Letter
Immunol Cell Biol Ju 83 344 2005 10.1111/j.1440-1711.2005.01330.x Immunity to melanoma mediated by 4-1BB is associated with enhanced activity of tumour-infiltrating lymphocytes
Blood Chester 131 49 2018 10.1182/blood-2017-06-741041 Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.